- Patients Patients
Reproductive Genetics Testing
Patient Resources
Cost & Billing
- Providers Providers
- Genetic Counseling
- Login Login
- Estimate My Cost
Women's Health Testing
Annual screening with iFOBT has been shown in peer-reviewed literature to detect a majority of prevalent colorectal cancer (CRC) in an asymptomatic population at the time of testing, and is an acceptable option for CRC screening in average-risk adults who are 45 years and older.
Informational Material